Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-010366
Filing Date
2025-05-14
Accepted
2025-05-14 17:07:02
Documents
9
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 838297
2 GRAPHIC formdef14a_001.jpg GRAPHIC 5530
3 GRAPHIC formdef14a_002.jpg GRAPHIC 2377
4 GRAPHIC formdef14a_003.jpg GRAPHIC 5530
5 GRAPHIC formdef14a_005.jpg GRAPHIC 2377
6 GRAPHIC formdef14a_007.jpg GRAPHIC 39940
7 GRAPHIC proxy_001.jpg GRAPHIC 399069
8 GRAPHIC proxy_002.jpg GRAPHIC 535713
9 GRAPHIC proxy_003.jpg GRAPHIC 260502
  Complete submission text file 0001641172-25-010366.txt   2563505
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37648 | Film No.: 25946973
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)